|
Novartis' new heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs. ACE-inhibitor in landmark PARADIGM-HF trial
|
02 September 2014 |
|
Novartis provides drug candidate compounds to TB Alliance
|
20 August 2014 |
|
Novartis maintained strong innovation momentum in second quarter
|
17 July 2014 |
|
Novartis to license Google "smart lens" technology
|
15 July 2014 |
|
Novartis reinforces its leadership in research with new global guidelines for Investigator Initiated Trials (IITs)
|
08 July 2014 |
|
Novartis launches 7-Day Challenge to 'Live Like You' enabling people with MS to better understand their lives with MS
|
28 May 2014 |
|
More than 19,000 Novartis associates worldwide volunteer for local causes on Community Partnership Day
|
08 May 2014 |
|
Novartis delivered solid sales and profit growth in the first quarter of 2014
|
27 April 2014 |
|
Novartis announces portfolio transformation
|
22 April 2014 |
|
Novartis and Malaria No More provide two million antimalarial treatments to children in Zambia
|
07 April 2014 |